Erweitertes Kontinuierliches Analytüberwachungssystem
Anmelder: Dexcom, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4749952
- Anmeldetag
- 28. September 2011
- Veröffentlichung
- 27. Mai 2026
- Rechtsraum
- EP
- IPC
- A61B5/145, A61B5/157, H04B7/24H04B7/24
Abstract
The present invention relates generally to systems and methods for processing, transmitting, and displaying data received from continuous analyte sensor 10, such as a glucose sensor. In some embodiments, the continuous analyte sensor system 8 comprises a sensor electronics module 12 that includes power saving features. One feature includes a low power measurement circuit that can be switched between a measurement mode and a low power mode, in which charging circuitry continues to apply power to electrodes of a sensor during the low power mode. In addition, the sensor electronics module can be switched between in a low power storage mode higher power operational mode via a switch. The switch can include a reed switch or optical switch, for example. A validation routine can also be implemented to ensure an interrupt signal sent from the switch is valid. The continuous analyte sensor 10 can be physically connected to a sensor electronics module 12, which is in direct wireless communication with a plurality of different display devices 14, 16, 18, and/or 20.
Anmelder
- Firma
- Dexcom, Inc.
- Land
- 🇺🇸 USA
Dexcom ist ein US-amerikanisches Medizintechnikunternehmen, das kontinuierliche Blutzuckermesssysteme (CGM) für Diabetiker entwickelt. Das Patentportfolio konzentriert sich stark auf Medizintechnik und Gesundheit, ergänzt durch Software und Datenverarbeitung sowie Mess- und Kommunikationstechnik. Anmeldungen erstrecken sich von 2001 bis 2025.
566 Patente in unserer Datenbank
Vertreten von
-
Hoffmann Eitle
Hoffmann Eitle · München